Oxybuprocaine Hydrochloride/Fluorescein Sodium

盐酸奥布卡因/荧光素钠

Report date: 2023/02/02 17:59:24

Base Information

Drug NameOxybuprocaine Hydrochloride/Fluorescein Sodium
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsContrast agents
Global Approved IndicationsContrast agents
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2020/03/09
Country/TerritoryUnited States
CombinationsYes Oxybuprocaine HydrochlorideFluorescein Sodium
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBausch Health Ireland Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBausch Health Ireland Ltd
Inactive CompaniesN/A
Active IndicationsContrast agents
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A